(NASDAQ: AZTA) Azenta's forecast annual revenue growth rate of -1.84% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.43%.
Azenta's revenue in 2025 is $649,516,000.On average, 3 Wall Street analysts forecast AZTA's revenue for 2025 to be $27,135,412,804, with the lowest AZTA revenue forecast at $27,047,220,313, and the highest AZTA revenue forecast at $27,284,837,386. On average, 3 Wall Street analysts forecast AZTA's revenue for 2026 to be $28,626,277,155, with the lowest AZTA revenue forecast at $28,376,962,011, and the highest AZTA revenue forecast at $29,030,408,962.
In 2027, AZTA is forecast to generate $30,013,321,125 in revenue, with the lowest revenue forecast at $30,013,321,125 and the highest revenue forecast at $30,013,321,125.